You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Glycogen Storage Disease

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pompe Disease, Muscle Loss, Obesity Trial (Multi-ingredient supplement (PDT-MIS), Placebo (PLA))

Not yet recruiting
  • Pompe Disease
  • +7 more
  • Multi-ingredient supplement (PDT-MIS)
  • Placebo (PLA)
  • (no location specified)
Nov 8, 2023

Biospecimen in Pediatric Patients and Adult Guardians Diagnosed

Recruiting
  • Glycogen Storage Disease Type IB
  • Specimen Donation
  • Woburn, Massachusetts
    Sanguine BioSciences, Inc.
Jun 22, 2023

Glycogen Storage Disease VI, GLYCOGEN STORAGE DISEASE IXa1, GLYCOGEN STORAGE DISEASE IXa2 Trial in Durham (No intervention)

Recruiting
  • Glycogen Storage Disease VI
  • +4 more
  • No intervention
  • Durham, North Carolina
    Duke University
Jul 27, 2022

Glycogen Storage Disease Type IB Trial in Shanghai (Empagliflozin)

Recruiting
  • Glycogen Storage Disease Type IB
  • Shanghai, Shanghai, China
    Xinhua Hospital, Shanghai Jiao Tong University School of Medicin
Jul 17, 2023

Carbon-13 Magnetic Resonance Spectroscopy in Glycogen Storage

Recruiting
  • Glycogen Storage Disease
  • +2 more
  • No intervention
  • Copenhagen, Copenhange, Denmark
    Neuromuscular Research Unit, 8077
Oct 26, 2022

Pompe Disease -Non-invasive Magnetic Resonance Exploratory Pilot

Not yet recruiting
  • Pompe Disease
  • McArdle Disease
  • Siemens Magnetom 7T Plus
  • Vienna, Austria
    Medical University of Vienna
Jul 5, 2023

Hypoglycemia in Glycogen Storage Disease Type III

Recruiting
  • Glycogen Storage Disease Type III
  • No Intervention
  • Philadelphia, Pennsylvania
  • +1 more
Jul 22, 2022

Pompe Disease, Glycogen Storage Disease Type II (GSD-II), Acid Maltase Deficiency Disease Trial in Gainesville, Decatur, Detroit

Completed
Has Results
  • Pompe Disease
  • +2 more
  • alglucosidase alfa
  • Gainesville, Florida
  • +2 more
Jul 29, 2022

Glycogen Storage Disease Type IV, Adult Polyglucosan Body Disease Trial in Durham (No intervention)

Recruiting
  • Glycogen Storage Disease Type IV
  • Adult Polyglucosan Body Disease
  • No intervention
  • Durham, North Carolina
    Duke University Medical Center
May 20, 2022

Glycogen Storage Disease Type II, Pompe Disease (Late-onset) Trial in Milan (Inspiratory Muscle Training (IMT), Inspiratory

Recruiting
  • Glycogen Storage Disease Type II
  • Pompe Disease (Late-onset)
  • Inspiratory Muscle Training (IMT)
  • Inspiratory Muscle Training (IMT) + Air Stacking
  • Milan, Italy
    IRCCS S. Maria Nascente - Fondazione Don Carlo Gnocchi
Jul 11, 2023

Glycogen Storage Disease Type II Infantile Onset Trial in Gainesville (Cipaglucosidase alfa (ATB200), Miglustat (AT2221))

Recruiting
  • Glycogen Storage Disease Type II Infantile Onset
  • Gainesville, Florida
    University of Florida Clinical Research Center
Jan 18, 2023

Glycogen Storage Disease Type IA Trial in Groningen ([6,6-2H2]glucose)

Completed
  • Glycogen Storage Disease Type IA
  • [6,6-2H2]glucose
  • Groningen, Netherlands
    University of Groningen, UMC Groningen
Feb 10, 2022

Glycogen Storage Disease Type IA Trial in Worldwide (genetic, other, drug)

Recruiting
  • Glycogen Storage Disease Type IA
  • DTX401
  • +3 more
  • Orange, California
  • +16 more
Jan 13, 2023

Adeno-Associated Virus Antibody Study in Subjects OTC

Recruiting
  • Ornithine Transcarbamylase Deficiency
  • +2 more
    • Akron, Ohio
    • +2 more
    Jul 22, 2022

    Glycogen Storage Disease Trial in United States (mRNA-3745)

    Recruiting
    • Glycogen Storage Disease
    • Farmington, Connecticut
    • +4 more
    Jun 10, 2022

    Natural History of Pompe Disease

    Recruiting
    • Glycogen Storage Disease Type II, Adult
      • Garches, Hauts-de-Seine, France
        Hôpital Raymond Poincaré
      Apr 20, 2022

      Glycogen Storage Disease Type III Trial in Worldwide (biological, other, drug)

      Recruiting
      • Glycogen Storage Disease Type III
      • UX053
      • +4 more
      • Orange, California
      • +9 more
      Jul 22, 2022

      GSD1 Trial in Worldwide (DTX401)

      Completed
      Has Results
      • GSD1
      • DTX401
      • steroid regimen
      • Farmington, Connecticut
      • +5 more
      Oct 25, 2022

      Pompe Disease (Late-onset) Trial (No Intervention)

      Not yet recruiting
      • Pompe Disease (Late-onset)
      • No Intervention
      • (no location specified)
      Nov 21, 2023

      Glycogen Storage Disease Type I Trial in Durham (Triheptanoin)

      Completed
      • Glycogen Storage Disease Type I
      • Durham, North Carolina
        Duke University Medical Center
      Dec 14, 2021

      Glycogen Storage Disease Type II Trial in Worldwide (Alglucosidase alfa GZ419829)

      Recruiting
      • Glycogen Storage Disease Type II
      • Alglucosidase alfa GZ419829
      • Leuven, Belgium
      • +8 more
      Jan 17, 2023

      Mucopolysaccharidosis I, Mucopolysaccharidosis II, Mucopolysaccharidosis IV A Trial in San Francisco (There is no intervention)

      Recruiting
      • Mucopolysaccharidosis I
      • +7 more
      • There is no intervention
      • San Francisco, California
        University of California San Francisco
      Nov 9, 2022

      Pompe Disease, Glycogen Storage Disease Type II (GSD-II), Glycogenesis 2 Acid Maltase Deficiency Trial in Israel, United States

      Terminated
      Has Results
      • Pompe Disease
      • +2 more
      • Myozyme® (alglucosidase alfa)
      • Louisville, Kentucky
      • +4 more
      Mar 24, 2022

      Glycogen Storage Disease Type II Trial in France (Avalglucosidase alfa (GZ402666))

      Recruiting
      • Glycogen Storage Disease Type II
      • Avalglucosidase alfa (GZ402666)
      • Brest, France
      • +9 more
      Jul 22, 2022

      Pompe Disease Trial in New York, Fairfax (biological, drug, other)

      Not yet recruiting
      • Pompe Disease
      • Cipaglucosidase alfa
      • +3 more
      • New York, New York
      • +1 more
      Nov 2, 2023